The 10-year plan starts today and gives recommendations for a range of scientific disciplines to better address seasonal flu and prepare for the next flu pandemic.
An analysis of US health insurance data found that post-discharge prophylactic antibiotics are commonly prescribed after mastectomy, but provide only a small reduction in surgical-site infections (SSIs), researchers reported today in Infection Control & Hospital Epidemiology.
People who received the flu vaccine prior to having COVID-19 had less risk of sepsis, stroke, deep vein thrombosis (DVT), and disease requiring emergency or intensive care, according to a study presented at the European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) this year.
The global prevalence of vancomycin-resistant Staphylococcus aureus (VRSA) has more than tripled in the past two decades, according to a systematic review and meta-analysis yesterday in Antimicrobial Resistance & Infection Control.
A modeling study yesterday suggests that the first human case of COVID-19 likely occurred in or around November 2019 in China, with the most likely date of origin being Nov 17. The study was published in PLOS Pathogens.
Only a few countries reported sporadic flu detection, mostly involving influenza B, the World Health Organization (WHO) said in its latest global flu update, which covers the end of May and the first week of June.
New data show no adverse outcomes in infants exposed to the flu vaccine in utero.
A crowdsourcing appeal for creative solutions for safely reopening the University of North Carolina at Chapel Hill amid the COVID-19 pandemic in fall 2020 netted 82 submissions from 110 students, faculty, and staff, according to a qualitative study today in JAMA Network Open.
Infants born to women with COVID-19 have a low chance of contracting the disease from their mothers and having complications, according to a study published yesterday in JAMA.
The World Health Organization (WHO) today announced that its influenza vaccine strain selection committee has made its recommendations for the Northern Hemisphere's 2021-22 flu season, which swaps out the two influenza A strains for both the egg-based and cell-based or recombinant vaccines.
